BridgeMD
New treatment option for Healthy
Official title Empowering Adolescents to Lead Change Using Health Data
ClinicalTrials.gov ID: NCT04963426
What this study is testing
- What it's testing
- This study is a cluster randomized trial carried out in schools of secondary cities of four low- and middle income countries. Baseline surveys in 30 randomly selected schools will assess the health behaviours of 13-17 year old students as well as school policies and practices.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 17
You may be able to join if
- School going
- Aged 13-17 years
You likely can't join if
- Not going to school
- Outside the age range 13-17 years
The study team makes the final eligibility decision.
Where it's taking place
- Sekondi-Takoradi, Ghana
- Jaipur, India
- Spanish Town, Jamaica
- Fes, Morocco
- Geneva, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sekondi-Takoradi, Ghana; Jaipur, India; Spanish Town, Jamaica; Fes, Morocco; Geneva, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.